Skip to main content
Thursday 30 March 2023
twitter linkedin facebook rss
User account menu
  • Sign up
Home
Pharmaphorum menu first category
  • News
  • Views & Analysis
  • Deep Dive
  • Webinars
  • Podcasts
  • Videos
  • White Papers
  • Events
close
    SECTION
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Videos
    • White Papers
    • Events
Channels
    Channels
    • Sales & Marketing
    • R&D
    • Digital
    • Market Access
    • Oncology
    • Patients
    • Spotlight
Channels
  • Sales & Marketing
  • R&D
  • Digital
  • Market Access
  • Oncology
  • Patients
  • Spotlight
    SUB NAVIGATION
    • Live Coverage
    • Partner Content
    • About us
    • Work for us
    • Contribute
    • Contact us
    • Advertise

Newsletters and Deep Dive digital magazine

 
 
Sign up
twitter linkedin facebook rss
Sign in

Eye on ESMO 2016

Views & Analysis
Card image cap
Adam Jeffery
8 October, 2016

2016

FacebookTwitterLinkedin
Bookmark this


R&D
Card image cap
Partner Content

2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit

2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit re

Views & Analysis
Card image cap

Exclusive coverage of the 2016 inaugural 'Inspiring Hope' Id...

R&D
Card image cap
Sponsored

Trials and tribulations of drug development

  What does it take to establish new treatments for rare diseases?

R&D
Card image cap

Into the bowels of gut research

For people living with Inflammatory Bowel Disease (IBD), navigating life around the risk of flare-ups can be a messy and exhausting challenge.

Sales & Marketing
Card image cap
Sponsored

Empowering MSLs to be the kings of Pharma’s New Frontier

The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, al

Digital
Card image cap
Sponsored

Artificial intelligence in medicine

Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare.

R&D
Card image cap
Partner Content

Novel Nasal Formulation & Delivery Summit

Not only has the pandemic fuelled interest in new modalities research, but it has also triggered a renaissance of formulation approaches amongst biopharma to bring new wave of drug substances and t

R&D
Card image cap
Partner Content

2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy S...

Exciting results are expected this year, from multiple mid and late stage clinical trials and involving a broad array of adenosine drugs including CD73, CD39 and A2AR!

 
 

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

2016

breakthough

Cancer

clinical trial

ESMO

immuno-oncology

Oncology

patient

Pharma

treatment

Category : Views & Analysis /

Editor's Picks

  1. Digital health firm Pear considers future as cash dwindles
  2. Roche, Lilly join forces on blood test for Alzheimer’s
  3. FDA rejects AbbVie’s continuous Parkinson’s therapy
  4. MHRA unveils big shakeup in UK clinical trials regs
  5. Project seeks to shape digital health reimbursement in APAC
News
Card image cap

Clinical trial go-between Inato raises $20m

Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial platform, which connect sponsors with its network of thous

R&D
Card image cap
Sponsored

Trials and tribulations of drug development

  What does it take to establish new treatments for rare diseases?

Pharmaphorum Menu
  • Digital
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Market Access
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Oncology
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Patients
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • R&D
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Sales & Marketing
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Spotlight on
    • Frontiers Health 2022
    • The Future of Generics

Sign up for email newsletters and Deep Dive

 
 
rss facebook linkedin twitter
Pharmaphorum
About us Advertising Contact us
Contribute Cookie Policy Privacy Policy
Terms & Conditions Work for us
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company